Amare Global FTC Lawsuit Mental Health Income Claims, Did Its Supplements Really Treat Depression, Anxiety, and ADHD? — FTC v. Amare Global Holdings Inc., C.D. Cal. (2026)
Amare Global Holdings Inc. is facing a federal lawsuit — filed by the FTC on June 2, 2026, in the U.S. District Court for the Central District of California — alleging the company falsely told consumers its dietary supplements could treat depression, anxiety, and ADHD in children and adults, while separately misleading people who signed…
